OBJECTIVES: Upon completion of this activity, the participant should be able to:

1: Describe the pathophysiology of anesthetic neurotoxicity.

2: Identify patient groups at risk of anesthetic neurotoxicity.

3: Explain the clinical findings of anesthetic neurotoxicity.    

4: Review anesthetic drug classes associate with neurotoxicity and its management by an interprofessional team.  

FACULTY DISCLOSURE:  Dr. Betsy Regier has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNER DISCLOSURE: William Culp, MD and Craig Lilie, MD have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Amy.Sanders@BSWHealth.org

MEETING LINK: 

Microsoft Teams meeting

Join on your computer or mobile app

Click here to join the meeting

Or call in (audio only)

+1 469-208-1641,,748426509#   United States, Dallas

Phone Conference ID: 748 426 509#

Find a local number | Reset PIN

Learn More | Meeting options